AI's Potential in Healthcare Boosts Moderna Stock Amid $500 Billion AI Infrastructure Investment

Moderna stock jumps on AI healthcare prospects By Investing.com

Investing.com -- Moderna , Inc. (NASDAQ:MRNA) shares surged 14% following remarks by Oracle (NYSE:ORCL) Chairman Larry Ellison on the transformative potential of artificial intelligence (AI) in healthcare, particularly in early cancer detection and the development of personalized vaccines. Ellison's comments underscored the potential for AI to revolutionize healthcare by identifying cancer early through blood tests and enabling the rapid creation of individualized vaccines. The boost in Moderna's stock also comes on the heels of President Donald Trump's announcement of a $500 billion private sector investment in AI infrastructure, which includes a joint venture known as Stargate with participation from OpenAI, SoftBank (TYO:9984), and Oracle. This initiative is set to bolster AI's role in healthcare by establishing data centers and creating jobs. The Oracle Chairman elaborated on how minuscule fragments of tumors circulating in the blood could be detected using AI-powered blood tests, leading to early cancer diagnosis. Subsequently, AI could play a crucial role in gene-sequencing cancerous tumors to formulate personalized vaccines. These mRNA vaccines could be produced robotically within 48 hours, offering a quick and personalized response to cancer treatment. Although no specific analyst comments were provided, the market's reaction to Ellison's vision and the significant private sector investment in AI infrastructure reflects a strong investor interest in the intersection of healthcare and technology. Moderna's leap in share price is indicative of the optimism surrounding the company's potential role in this AI-driven healthcare future. The implications of AI in healthcare, especially in the context of Moderna's expertise in mRNA technology, appear to be resonating with investors. As the industry moves towards more personalized and efficient healthcare solutions, companies like Moderna stand at the forefront of these advancements, potentially reaping the benefits of increased investment and innovation in the field.

Moderna Shares Are Up Today: What's Going On? - Moderna (NASDAQ:MRNA)

President Donald Trump announces a $500 billion private sector investment in AI infrastructure. Moderna Inc MRNA shares are trading higher Wednesday after Oracle Chairman Larry Ellison discussed the potential of artificial intelligence (AI) to revolutionize health care. What To Know: Ellison highlighted AI's ability to analyze blood tests for early cancer detection, identifying circulating tumor fragments and gene-sequencing cancerous tumors to create individualized vaccines, according to Economic Times. Using AI-driven automation, such mRNA vaccines could be produced robotically within 48 hours, significantly accelerating personalized cancer treatment. The discussion took place at a White House event, where President Donald Trump announced a $500 billion private sector investment in AI infrastructure. The initiative, involving a joint venture called Stargate by OpenAI, SoftBank and Oracle, aims to construct large-scale data centers and create over 100,000 jobs. Trump emphasized that the investment is part of a broader strategy to advance AI capabilities in the U.S. Ellison stated that the first data centers under the Stargate project are already under construction in Texas, with plans for 20 facilities measuring half a million square feet each. These centers will support AI applications in health care, including electronic health record analysis and advanced diagnostic tools. The announcement potentially reinforced optimism around AI's role in transforming medical technologies, boosting investor confidence in Moderna and its potential role in AI-driven healthcare advancements. MRNA Price Action: Moderna shares closed Wednesday up 7.27% at $38.50, according to Benzinga Pro. Read Next: Amazon's $100M Land Deal Launches Its $10-Billion Data Center Project In Ohio Photo: Shutterstock. MRNAModerna Inc$38.507.27%WatchlistOverviewMarket News and Data brought to you by Benzinga APIs